Use of tetrahydrobiopterins in the preparation of a medicament for the treatment of infantile autism

摘要

A pharmaceutical composition for the treatment of infantile autism which contains tetrahydrobiopterin or a derivative thereof as a major effective ingredient and 5-hydroxytryptophan and/or L-DOPA as an optional auxiliary effective ingredient is provided.